The headache research priorities: Research goals from the American Headache Society and an international multistakeholder expert group. Headache. 2024; 64:912-930.
.Impact of preventive pill-based treatment on migraine days: A secondary outcome study of the Childhood and Adolescent Migraine Prevention (CHAMP) trial and a comparison of self-report to nosology-derived assessments. Headache. 2023; 63:805-812.
.Multimodal Assessment of Medication Adherence Among Youth With Migraine: An Ancillary Study of the CHAMP Trial. Journal of Pediatric Psychology. 2022; 47:376-387.
.Trajectory of treatment response in the child and adolescent migraine prevention (CHAMP) study: A randomized clinical trial. Cephalalgia: an international journal of headache. 2022; 42:44-52.
.Prevalence of Headache Days and Disability 3 Years After Participation in the Childhood and Adolescent Migraine Prevention Medication Trial. JAMA Network Open. 2021; 4:e2114712.
.Identification of neural and psychophysical predictors of headache reduction after cognitive behavioral therapy in adolescents with migraine. PAIN. 2021; 162:372-381.
.Alterations in Brain Function After Cognitive Behavioral Therapy for Migraine in Children and Adolescents. Headache. 2020; 60:1165-1182.
.Treatment Adherence in Child and Adolescent Chronic Migraine Patients: Results From the Cognitive-Behavioral Therapy and Amitriptyline Trial. The Clinical Journal of Pain. 2017; 33:892-898.
.The Childhood and Adolescent Migraine Prevention (CHAMP) Study: "What Do We Do Now? ". Headache. 2017; 57:180-183.
.Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine. The New England Journal of Medicine. 2017; 376:115-124.
.Cognitive Behavioral Therapy plus Amitriptyline for Children and Adolescents with Chronic Migraine Reduces Headache Days to ≤4 Per Month. Headache. 2016; 56:711-716.
.Cognitive-Behavioral Therapy: How Medical Providers Can Increase Patient and Family Openness and Access to Evidence-Based Multimodal Therapy for Pediatric Migraine. Headache. 2015; 55:1382-1396.
.Behavioral and nutritional treatment for preschool-aged children with cystic fibrosis: a randomized clinical trial. JAMA pediatrics. 2015; 169:e150636.
.Logan Wright Award: Team science, team care, team training, and team leadership: my experience. Journal of Pediatric Psychology. 2014; 39:277-282.
.Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: a randomized clinical trial. Journal of the American Medical Association (JAMA). 2013; 310:2622-2630.
.Youth with high-frequency headaches due to migraine are more vulnerable to non-cephalic pain complaints. Headache. 2025; 65:655-657.
.Behavioral interventions for migraine prevention: A systematic review and meta-analysis. Headache. 2025; 65:668-694.
.Single arm feasibility trial of a mobile application for adolescent migraine management. Pain Medicine. 2025; 26:170-172.
.Elexacaftor/tezacaftor/ivacaftor and mental health: A workshop report from the Cystic Fibrosis Foundation's Prioritizing Research in Mental Health working group. Journal of Cystic Fibrosis. 2025; 24:301-309.
.Behavior and migraine virtual issue. Headache. 2025; 65:203-205.
.2025; 3:2.
. The impact of neuroscience education therapy, behavioral economics, and digital navigators on patient migraine treatment adherence to a mobile health application: a prospective pilot randomized controlled trial.The 2024 Scottsdale Headache Symposium: A banner year. Headache. 2024; 64:1179-1180.
.Not their fault: Mental health characteristics of parents with migraine and the migraine status of their children. Headache. 2024; 64:1143-1145.
.The headache research priorities: Research goals from the American Headache Society and an international multistakeholder expert group. Headache. 2024; 64:912-930.
.Clinic-Based Characterization of Adolescents and Young Adults With Migraine: Psychological Functioning, Headache Days, and Disability. Neurology: Clinical Practice. 2024; 14:e200294.
.2024; 102.
. Randomized Controlled Trial of a Smartphone-based Preventive Migraine Self-management Program in the Emergency Department Setting: A Promising Teachable Moment (S22.004). Neurology.Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update. Headache. 2024; 64:333-341.
.Preliminary prospective observational investigation of clinical outcomes among treatment-seeking youth with continuous headache. Headache. 2024; 64:319-322.
.Commentary: Enhancing Clinical Care for Patients With Early Childhood Concussion. Journal of Pediatric Psychology. 2023; 48:982-983.
.Characterization of Migraine in Children and Adolescents With Generalized Joint Hypermobility: A Case-Control Study. Neurology: Clinical Practice. 2023; 13:e200188.
.The 2023 Scottsdale Headache Symposium. Headache. 2023; 63:1330-1331.
.Melatonin for migraine prevention in children and adolescents: A randomized, double-blind, placebo-controlled trial after single-blind placebo lead-in. Headache. 2023; 63:1314-1326.
.Biopsychosocial treatment response among youth with continuous headache: A retrospective, clinic-based study. Headache. 2023; 63:942-952.
.Impact of preventive pill-based treatment on migraine days: A secondary outcome study of the Childhood and Adolescent Migraine Prevention (CHAMP) trial and a comparison of self-report to nosology-derived assessments. Headache. 2023; 63:805-812.
.Virtual issue: Recent advances in pediatric headache: Bridging the data gap. Headache. 2023; 63:305-306.
.Bridging the gap between preclinical scientists, clinical researchers, and clinicians: From animal research to clinical practice. Headache. 2023; 63:25-39.
.Management of Chronic Migraine in Children and Adolescents: Where are We in 2022?. Pediatric Health, Medicine and Therapeutics. 2022; 13:309-323.
.New insight into the neural mechanisms of migraine in adolescents: Relationships with sleep. Headache. 2022; 62:668-680.
.Multimodal Assessment of Medication Adherence Among Youth With Migraine: An Ancillary Study of the CHAMP Trial. Journal of Pediatric Psychology. 2022; 47:376-387.
.Structural lung disease in preschool children with cystic fibrosis: An 18 month natural history study. Journal of Cystic Fibrosis. 2022; 21:e165-e171.
.Predictors of Improvement in Pediatric Chronic Migraine: Results from the Cognitive-Behavioral Therapy and Amitriptyline Trial. Journal of Clinical Psychology in Medical Settings. 2022; 29:113-119.
.Psychological Interventions for Pediatric Headache Disorders: A 2021 Update on Research Progress and Needs. Current Pain and Headache Reports. 2022; 26:85-91.
.Trajectory of treatment response in the child and adolescent migraine prevention (CHAMP) study: A randomized clinical trial. Cephalalgia: an international journal of headache. 2022; 42:44-52.
.Elsevier; Elsevier; 2022.
. Chapter 13 Acute behavioral headache management ☆. Pediatric Headache. :Elsevier; Elsevier; 2022.
. Chapter 17 Preventive behavioral headache management ☆. Pediatric Headache. :Prevalence of Headache Days and Disability 3 Years After Participation in the Childhood and Adolescent Migraine Prevention Medication Trial. JAMA Network Open. 2021; 4:e2114712.
.Learning the full impact of migraine through patient voices: A qualitative study. Headache. 2021; 61:1004-1020.
.The value of the patient perspective in understanding the full burden of migraine. Headache. 2021; 61:985-987.
.The promise of mechanistic approaches to understanding how youth with migraine get better-An Editorial to the 2020 Members' Choice Award Paper. Headache. 2021; 61:803-804.
.2021; 96.
. Joint Hypermobility Syndrome in Children and Adolescents with Headache: a retrospective study (2818). Neurology.Virtual issue: Kids (with headache disorders) are not just little adults (with headache disorders). Headache. 2021; 61:563-564.
.Spatial aspects of pain modulation are not disrupted in adolescents with migraine. Headache. 2021; 61:485-492.
.Introduction of a smartphone based behavioral intervention for migraine in the emergency department. General Hospital Psychiatry. 2021; 69:12-19.
.Identification of neural and psychophysical predictors of headache reduction after cognitive behavioral therapy in adolescents with migraine. PAIN. 2021; 162:372-381.
.